| P2093 | author name string | Carolyn Mold | |
| | Terry W Du Clos | |
| | Andres Peisajovich | |
| | Lorraine Marnell | |
| P2860 | cites work | Regulation of complement activation by C-reactive protein | Q22010264 |
| | Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis | Q24338918 |
| | C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity | Q24675774 |
| | SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS | Q24684141 |
| | The physiological structure of human C-reactive protein and its complex with phosphocholine | Q27618638 |
| | Fcgamma receptors: old friends and new family members | Q28291895 |
| | C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction | Q33883883 |
| | Effect of alcohol consumption on systemic markers of inflammation | Q33938498 |
| | Function of C-reactive protein | Q33942143 |
| | Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus | Q33974263 |
| | Targeting C-reactive protein for the treatment of cardiovascular disease. | Q33995386 |
| | C-reactive protein: a pentraxin with anti-acetylcholine activity. | Q34004401 |
| | Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction | Q34055000 |
| | Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group | Q34064191 |
| | A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells | Q34064320 |
| | C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease | Q34311841 |
| | C-reactive Protein | Q34344434 |
| | Allelic spectrum of the natural variation in CRP. | Q34573945 |
| | Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses | Q35119902 |
| | Generation of C-reactive protein and complement components in atherosclerotic plaques | Q35746446 |
| | C-reactive protein: risk marker or mediator in atherothrombosis? | Q35775733 |
| | Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia | Q35963030 |
| | Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera | Q36273294 |
| | C-reactive protein is protective against Streptococcus pneumoniae infection in mice | Q36345931 |
| | Exaggerated neointima formation in human C-reactive protein transgenic mice is IgG Fc receptor type I (Fc gamma RI)-dependent. | Q36357402 |
| | The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. | Q36375211 |
| | A systematic review of the association between circulating concentrations of C reactive protein and cancer | Q36910671 |
| | C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk | Q36942121 |
| | C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific | Q37175275 |
| | C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI). | Q38912827 |
| | C-reactive protein binding specificities: artificial and natural phospholipid bilayers | Q40333577 |
| | Association of common CRP gene variants with CRP levels and cardiovascular events. | Q40375395 |
| | Analysis of binding sites in human C-reactive protein for Fc{gamma}RI, Fc{gamma}RIIA, and C1q by site-directed mutagenesis | Q40425734 |
| | Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. | Q40436739 |
| | C-reactive protein promotes monocyte chemoattractant protein-1--mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes | Q40511322 |
| | Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcgamma receptors | Q40691926 |
| | C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study | Q40828366 |
| | Serum amyloid P-component is an acute-phase reactant in the mouse | Q41461262 |
| | Affinity of C-reactive protein toward FcgammaRI is strongly enhanced by the gamma-chain | Q42109419 |
| | C-Reactive Protein Decreases Prostacyclin Release From Human Aortic Endothelial Cells | Q42450459 |
| | The C-reactive protein (+)1444C/T alteration modulates the inflammation and coagulation response in human endotoxemia | Q42499951 |
| | C-reactive protein (CRP) binding to the Sm-D protein of snRNPS. Identification of a short polypeptide binding region | Q42622859 |
| | Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women | Q44273290 |
| | Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score | Q44497544 |
| | Effect of C-reactive protein on chemokine expression in human aortic endothelial cells | Q44792733 |
| | Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence | Q44810016 |
| | C-reactive protein levels and outcomes after statin therapy | Q45213511 |
| | Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease | Q45213515 |
| | Genetic variation in the CRP promoter: association with systemic lupus erythematosus | Q46261093 |
| | C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathw | Q46424647 |
| | Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects | Q46463135 |
| | FcgammaRIIB mediates C-reactive protein inhibition of endothelial NO synthase | Q46790570 |
| | Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998. | Q46835230 |
| | Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein. | Q46873024 |
| | The effect of different doses of fluvastatin on inflammatory markers in the early phase of acute coronary syndrome | Q46940180 |
| | Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats | Q47400800 |
| | Oral contraceptive use and increased plasma concentration of C-reactive protein. | Q51535496 |
| | Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. | Q52529090 |
| | Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. | Q54750642 |
| | Contribution of Clinical Correlates and 13 C-Reactive Protein Gene Polymorphisms to Interindividual Variability in Serum C-Reactive Protein Level | Q57073061 |
| | Human CRP Gene Polymorphism Influences CRP Levels | Q57243067 |
| | The TNF-α G-308A polymorphism is associated with C-reactive protein levels: The HERITAGE Family Study | Q57303564 |
| | Association between SLE nephritis and polymorphic variants of the CRP and Fc RIIIa genes | Q58190252 |
| | Independent prognostic value of C-reactive protein and coronary artery disease extent in patients affected by unstable angina | Q58230214 |
| P433 | issue | 3 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 379-390 | |
| P577 | publication date | 2008-05-01 | |
| P1433 | published in | Expert Review of Clinical Immunology | Q15733763 |
| P1476 | title | C-reactive protein at the interface between innate immunity and inflammation | |
| P478 | volume | 4 | |